A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease

American Journal of Clinical Pathology

Volumn 141, Issue 2, 2014, Pages 256-261

  Harm, Sarah K ^a,b   Yazer, Mark H ^a,b   Monis, Grace F ^c   Triulzi, Darrell J ^a,b   AuBuchon, James P ^c,d   Delaney, Meghan ^c,d  

^a INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

Author keywords

Alloantibody; Centralized transfusion service; Database; Delayed hemolytic reaction; Evanescence; Red blood cell; Sickle cell

Indexed keywords

ALLOANTIBODY; ANTIBODY; EVANESCED ANTIBODY; UNCLASSIFIED DRUG;

ALLOIMMUNIZATION; ARTICLE; BLOOD GROUP INCOMPATIBILITY; CENTRALIZED TRANSFUSION SERVICE MODEL; DATA BASE; ERYTHROCYTE TRANSFUSION; HOSPITAL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; NONINDEX HOSPITAL; PATIENT SAFETY; PRIORITY JOURNAL; SEROLOGY; SICKLE CELL ANEMIA; BLOOD; BLOOD GROUP TYPING; CENTRALIZED TRANSFUSION SERVICE; DELAYED HEMOLYTIC REACTION; ERYTHROCYTE; EVANESCENCE; FACTUAL DATABASE; IMMUNOLOGY; METHODOLOGY; SICKLE CELL;

ALLOANTIBODY; CENTRALIZED TRANSFUSION SERVICE; DATABASE; DELAYED HEMOLYTIC REACTION; EVANESCENCE; RED BLOOD CELL; SICKLE CELL;

ANEMIA, SICKLE CELL; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; HUMANS; ISOANTIBODIES;

EID: 84895125818     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP47QAAXTOZEKJ     Document Type: Article

References (14)

1. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease: the Cooperative Study of Sickle Cell Disease. Blood. 1990;76:1431-1437.
2. Hendrickson JE, Chadwick TE, Roback JD, et al. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007;110:2736-2743.
3. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322:1617-1621.
4. Miller ST, Kim HY, Weiner DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion. 2013;53:704-709.
5. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987;27:94-98.
6. Lasalle-Williams M, Nuss R, Le T, et al. Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME). Transfusion. 2011;51:1732-1739.
7. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012;120:528-537.
8. Yazer M. The Pittsburgh centralized transfusion model: less is more. Transfusion. 2007;47:164S-168S, discussion 182S-183S.
9. Delaney M, Dinwiddie S, Nester TN, et al. The immunohematologic and patient safety benefits of a centralized transfusion database. Transfusion. 2013;53:771-776.
10. MacIvor D, Triulzi DJ, Yazer MH. Enhanced detection of blood bank sample collection errors with a centralized patient database. Transfusion. 2009;49:40-43.
11. Vichinsky EP. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Immunohematology. 2012;28:20-23.
12. Simpson M. Strategies for Centralized Blood Services. Bethesda, MD: AABB Press; 2006.
13. Schwickerath V, Kowalski M, Menitove JE. Regional registry of patient alloantibodies: first-year experience. Transfusion. 2010;50:1465-1470.
14. Schonewille H, van de Watering LM, Loomans DS, et al. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion. 2006;46:250-256.